Clinical trial
Effects of Endogenous and Exogenous Risk Factors in Patients With Alzheimer's and Parkinson's Diseases Using Clinical Indexes and Endophenotypes (Biomarkers) as Inputs to Artificial Intelligence
NCT07651085 is registered in ClinicalTrials.gov with IRCCS San Raffaele Roma as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Endogenous and Exogenous Risk Factors in Patients With Alzheimer's and Parkinson's Diseases Using Clinical Indexes and Endophenotypes (Biomarkers) as Inputs to Artificial Intelligence
- Lead sponsor
- IRCCS San Raffaele Roma
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- February 8, 2024
- Completion date
- July 20, 2027
- Enrollment
- 65 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
alzheimer disease, dementia, mild cognitive impairment, parkinson disease